- Published: December 2011
US Epilepsy Market Highlights - 2014
- ID: 2855234
- May 2014
- Region: United States
- Fore Pharma
The latest research, 'US Epilepsy Market Highlights – 2014', provides the US epilepsy market analysis, competitive landscape, and epilepsy drug sales forecast in the US.
The research includes the US epilepsy market size estimates for 2013, market share forecast for six years to 2019, epilepsy drugs market share, epilepsy drugs sales estimates, epilepsy drugs sales forecast, and epilepsy late stage pipeline products.
This research helps executives track competitor drugs sales and market share in the US epilepsy market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US epilepsy market.
SCOPE OF THE REPORT
- What are the drugs marketed in the US for treating epilepsy?
Identify drugs marketed in the US for treating epilepsy including trade name, molecule name, company, and year of launch.
- How big is the US epilepsy market?
Find out estimates for the US epilepsy market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
- What is my competitor’s drugs market share in the US epilepsy market?
You will know the market share of leading epilepsy brands in the US, including generics share.
- What are the key molecules in pipeline for epilepsy?
Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of epilepsy. Our coverage includes molecule, mechanism of action, and the originator.
- What is the future of the US epilepsy market?
Gain insights into how the US epilepsy market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
- Future epilepsy drugs forecast in the US
Find out how epilepsy drugs will be positioned in the US in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
Highlights of the Research:
- Marketed Epilepsy Drugs in the US
- The US Epilepsy Market Analysis
- Epilepsy Drugs Sales Analysis in the US
- Competitive Landscape in the US Epilepsy market
- Epilepsy Late Stage Pipeline
- The US Epilepsy Market Forecast
- Epilepsy Drugs Sales Forecast in the US
- Future Competitive Landscape SHOW LESS READ MORE >
1. Epilepsy - Disease Definition
2. Marketed Epilepsy Drugs in US
3. US Epilepsy Market Analysis
3a. US Epilepsy Market Size
3b. Drugs Sales in US Epilepsy Market
4. Competitive Landscape in US Epilepsy Market
4a. Drugs Market Share in US Epilepsy Market
4b. Generics Market Share in US Epilepsy Market
4c. Epilepsy Phase 3 Clinical Trial Pipeline Molecules
4c. Epilepsy Phase 2 Clinical Trial Pipeline Molecules
5. US Epilepsy Market – Future Market Outlook
5a. US Epilepsy Market Size Forecast
5b. Drug Sales Forecast in US Epilepsy Market
5c. Drugs Market Share in US Epilepsy Market
Table 1. Marketed Epilepsy Drugs in US, 2013
Table 2. US Epilepsy Market Size ($), 2010 – 2013
Table 3. Drugs Sales in US Epilepsy Market ($), 2013
Table 4. Epilepsy Phase 3 Clinical Trial Pipeline Molecules, 2014
Table 5: Epilepsy Phase 2 Clinical Trial Pipeline Molecules, 2014
Table 6. US Epilepsy Market Forecast ($), 2013 – 2019
Table 7: Drug Sales Forecast in US Epilepsy Market ($), 2013 – 2019
Figure 1. US Epilepsy Market Size ($), 2010 – 2013
Figure 2. Drugs Market Share in US Epilepsy Market (%), 2013
Figure 3. US Epilepsy Market Forecast ($), 2013 – 2019
Figure 4. Drugs Sales Forecast in US Epilepsy Market ($), 2013 – 2019
Figure 5: Drugs Market Share in US Epilepsy Market (%), 2019